[go: up one dir, main page]

MXPA02006593A - Dapsona topica para tratamiento del acne. - Google Patents

Dapsona topica para tratamiento del acne.

Info

Publication number
MXPA02006593A
MXPA02006593A MXPA02006593A MXPA02006593A MXPA02006593A MX PA02006593 A MXPA02006593 A MX PA02006593A MX PA02006593 A MXPA02006593 A MX PA02006593A MX PA02006593 A MXPA02006593 A MX PA02006593A MX PA02006593 A MXPA02006593 A MX PA02006593A
Authority
MX
Mexico
Prior art keywords
acne
treatment
dapsone
composition
topical dapsone
Prior art date
Application number
MXPA02006593A
Other languages
English (en)
Inventor
David W Osborne
Original Assignee
Atrix Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Atrix Lab Inc filed Critical Atrix Lab Inc
Publication of MXPA02006593A publication Critical patent/MXPA02006593A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Floor Finish (AREA)

Abstract

La presente invencion se relaciona con un metodo para el tratamiento del acne al aplicar topicamente una composicion dermatologica que comprende dapsona. Ademas de las lesiones inflamatorias, la composicion tambien trata el acne no inflamatorio. La composicion es formulada para incluir dapsona en un estado tanto disuelto como microparticulado.
MXPA02006593A 2002-02-20 2002-07-01 Dapsona topica para tratamiento del acne. MXPA02006593A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10/081,050 US20030157036A1 (en) 2002-02-20 2002-02-20 Topical dapsone for the treatment of acne

Publications (1)

Publication Number Publication Date
MXPA02006593A true MXPA02006593A (es) 2004-08-19

Family

ID=27733245

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02006593A MXPA02006593A (es) 2002-02-20 2002-07-01 Dapsona topica para tratamiento del acne.

Country Status (22)

Country Link
US (2) US20030157036A1 (es)
EP (1) EP1485059B1 (es)
JP (1) JP2005524651A (es)
KR (1) KR100864129B1 (es)
CN (1) CN1625384A (es)
AT (1) ATE353628T1 (es)
AU (1) AU2002306767B2 (es)
BR (1) BR0215606A (es)
CA (3) CA2776702C (es)
DE (1) DE60218227T2 (es)
DK (1) DK1485059T3 (es)
EA (1) EA008022B1 (es)
ES (1) ES2280629T3 (es)
IL (1) IL163650A0 (es)
IS (1) IS2454B (es)
MX (1) MXPA02006593A (es)
NO (1) NO20043877L (es)
NZ (1) NZ535363A (es)
PT (1) PT1485059E (es)
SI (1) SI1485059T1 (es)
WO (1) WO2003072071A1 (es)
ZA (1) ZA200407439B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003238630A1 (en) * 2002-05-21 2003-12-02 Immune Network Ltd. Use of 4-(4'-aminophenylsulphonyl)-benzoic acid and esters thereof as anti-inflammatory agents
WO2005016296A1 (en) * 2003-08-13 2005-02-24 Qlt Usa, Inc. Emulsive composition containing dapsone
US20060286108A1 (en) * 2005-06-16 2006-12-21 Bell Katherine A Topical compositions for the treatment of chronic wounds
KR100806051B1 (ko) 2006-09-06 2008-02-26 오교철 답손을 유효성분으로 함유하는 항진균용 약학 조성물
BRPI0808220A2 (pt) * 2007-03-21 2014-07-08 Dow Global Technologies Inc "composição de liberação controlada e método para liberar um ingrediente ativo à pele ou ao cabelo ao longo do tempo"
US20090041686A1 (en) * 2007-08-06 2009-02-12 Osborne David W Topical acne vulgaris composition with a sunscreen
WO2009061298A1 (en) * 2007-11-07 2009-05-14 Qlt Usa, Inc. Topical treatment with dapsone in g6pd-deficient patients
ES2775825T3 (es) * 2008-02-27 2020-07-28 Allergan Inc Dapsona para tratar la rosácea
CA2769640A1 (en) * 2009-07-30 2011-02-03 Allergan, Inc. Combination of dapsone with adapalene
US20110117182A1 (en) * 2009-07-30 2011-05-19 Allergan, Inc. Combination of dapsone with other anti-acne agents
CN103054792B (zh) * 2011-10-21 2017-06-06 重庆华邦制药有限公司 一种质量稳定的氨苯砜凝胶及其制备方法
KR20130063962A (ko) * 2011-12-07 2013-06-17 가천대학교 산학협력단 디아미노디페닐술폰을 포함하는 골량 저하 질환의 예방 또는 치료용 약학적 조성물
BR112015011673B1 (pt) 2012-11-20 2021-03-09 Allergan, Inc. composição e uso da mesma
EP3174536A1 (en) * 2014-07-31 2017-06-07 Allergan, Inc. Comparative efficacy and tolerability of dapsone 5% in adult versus adolescent females with acne vulgaris
CN108551760A (zh) * 2015-11-04 2018-09-18 阿勒根公司 使用局部氨苯砜组合物治疗寻常痤疮的方法
JP2023523035A (ja) * 2020-04-21 2023-06-01 コーエン ノーム キニーネ及び先天性免疫応答を生じさせるためのその使用
CN115887357B (zh) * 2022-11-28 2023-07-11 哈尔滨葵花药业有限公司 氨苯砜凝胶制剂及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3419009A1 (de) * 1984-05-22 1985-11-28 Dr. Karl Thomae Gmbh, 7950 Biberach Neue substituierte bis(4-aminophenyl)sulfone, ihre herstellung und ihre verwendung als arzneimittel
DE3603577A1 (de) * 1986-02-06 1987-08-13 Joachim K Prof Dr Seydel Neue substituierte 2,4-diamino-5-benzylpyrimidine, deren herstellung und deren verwendung als arzneimittel mit antibakterieller wirksamkeit
US5733572A (en) * 1989-12-22 1998-03-31 Imarx Pharmaceutical Corp. Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
US5863560A (en) * 1996-09-11 1999-01-26 Virotex Corporation Compositions and methods for topical application of therapeutic agents
US6277399B1 (en) * 1997-10-31 2001-08-21 New Horizon Diagnostics Corporation Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections
US6254866B1 (en) * 1997-10-31 2001-07-03 New Horizons Diagnostics Corporation Use of phage associated lytic enzymes for treating bacterial infections of the digestive tract
US6248324B1 (en) * 1997-10-31 2001-06-19 Vincent Fischetti Bacterial phage associated lysing enzymes for treating dermatological infections
US6200964B1 (en) * 1999-05-28 2001-03-13 Neutrogena Corporation Silicone gel containing salicylic acid
US6056955A (en) * 1999-09-14 2000-05-02 Fischetti; Vincent Topical treatment of streptococcal infections
US20040086469A1 (en) * 2002-10-30 2004-05-06 Osborne David W. Protectant for UV-induced skin damage

Also Published As

Publication number Publication date
EA008022B1 (ru) 2007-02-27
PT1485059E (pt) 2007-04-30
ZA200407439B (en) 2006-06-28
SI1485059T1 (sl) 2007-06-30
AU2002306767B9 (en) 2003-09-09
ES2280629T3 (es) 2007-09-16
EP1485059B1 (en) 2007-02-14
CA2477217A1 (en) 2003-09-04
NO20043877L (no) 2004-09-15
KR100864129B1 (ko) 2008-10-16
EA200401084A1 (ru) 2005-08-25
CN1625384A (zh) 2005-06-08
DE60218227D1 (de) 2007-03-29
HK1072010A1 (en) 2005-08-12
CA2776702A1 (en) 2003-09-04
WO2003072071A1 (en) 2003-09-04
IS7419A (is) 2004-08-20
NZ535363A (en) 2007-04-27
ATE353628T1 (de) 2007-03-15
US20030157036A1 (en) 2003-08-21
KR20040085214A (ko) 2004-10-07
CA2776702C (en) 2014-09-02
JP2005524651A (ja) 2005-08-18
DE60218227T2 (de) 2007-10-31
CA2477217C (en) 2012-07-17
IS2454B (is) 2008-11-15
AU2002306767A1 (en) 2003-09-09
BR0215606A (pt) 2004-12-07
CA2855045A1 (en) 2003-09-04
DK1485059T3 (da) 2007-05-07
IL163650A0 (en) 2005-12-18
EP1485059A4 (en) 2005-09-21
EP1485059A1 (en) 2004-12-15
US20070122435A1 (en) 2007-05-31
AU2002306767B2 (en) 2007-09-13

Similar Documents

Publication Publication Date Title
IL163650A0 (en) Topical dapsone for the treatment of acne
TW200505508A (en) Methods of administering a dermatological agent to a subject
WO2004043481A3 (en) Compositions containing peptide copper complexes and metalloproteinase inhibitors, and methods related thereto
AU3142195A (en) Dermatological compositions containing benzoyl peroxide and a compound reducing skin irritation
ATE421877T1 (de) Verwendung von totarol zur behandlung von pruritus
AU2002302587A1 (en) Acne treatment with lipooxigenase inhibitors
PL370795A1 (en) Composition based on etyllinoleate and triethylcitrate for the treatment of seborrhea and acne
WO2001096298A3 (en) 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase
TW200513271A (en) Topical treatment of skin conditions
WO2003099270A8 (en) Methods of treating allergic reactions
CA2157836A1 (en) L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses
BRPI0412424A (pt) composto, composição farmacêutica, método para tratar doenças dermatológicas ou cancerosas em um mamìfero, composição, e, método para tratar doenças relacionadas com a pele ou cancerosas
WO2004103353A3 (en) Topical treatment of sebum related skin conditions
BRPI0415678A (pt) compostos de pirimidina para o tratamento de inflamação
WO2003039453A3 (en) Novel benzoyl peroxide compositions for the treatment of dermatological disorders and methods for their use
WO2007022509A3 (en) Use of seh inhibitors as analgesics
WO2004071413A3 (en) Method and composition for potentiating an opiate analgesic
WO2001066101A3 (en) Treatment of psoriasis
AP1777A (en) Use of topical compositions for the control of microbial diseases of the nail.
WO2000073274A3 (de) Substituierte phenylcyclohexancarbonsäureamide und ihre verwendung als adenosinaufnahme-inhibitoren
ATE554757T1 (de) Verwendung von mindestens einem 2-alkyl-furan als wirkstoff zur depigmentierung oder aufhellung
SE9904059D0 (sv) Serine protease and topical retinoid compositions
AU2003258553A1 (en) Metal cluster nano-compounds for treating tumor diseases
AU2001285419A1 (en) Methods and compositions for treating skin ulcers by topical photodynamic therapy
AU2003251755A1 (en) Methods, compositions and kits for treating damage to excitable tissue

Legal Events

Date Code Title Description
GB Transfer or rights
HC Change of company name or juridical status
FA Abandonment or withdrawal